Three things to know:
1. The company requested approval for an updated package insert that includes 24-month follow-up data from subjects in the original clinical study.
2. i-Factor is a peptide enhanced bone graft that Cerapedics commercialized in 2016.
3. The biologic bone graft incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.
More articles on biologics:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
